Anticancer potential of metformin: focusing on gastrointestinal cancers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticancer potential of metformin: focusing on gastrointestinal cancers
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 87, Issue 5, Pages 587-598
Publisher
Springer Science and Business Media LLC
Online
2021-03-21
DOI
10.1007/s00280-021-04256-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes
- (2019) Elina Urpilainen et al. TUMOR BIOLOGY
- MicroRNA-7 as a potential therapeutic target for aberrant NF-κB-driven distant metastasis of gastric cancer
- (2019) Tingbo Ye et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metformin mediated microRNA-7 upregulation inhibits growth, migration, and invasion of non-small cell lung cancer A549 cells
- (2019) Jingying Dong et al. ANTI-CANCER DRUGS
- Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
- (2019) Takuma Yamashita et al. ANTI-CANCER DRUGS
- Nrf2 overexpression is associated with P -glycoprotein upregulation in gastric cancer
- (2018) Farhad Jeddi et al. BIOMEDICINE & PHARMACOTHERAPY
- Apoptosis: A Target for Anticancer Therapy
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma
- (2018) Xiao-Mei Gao et al. OncoTargets and Therapy
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling Pathway
- (2018) Jinhui Ye et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis
- (2018) NOBUFUMI SEKINO et al. ANTICANCER RESEARCH
- Metformin targets gastric cancer stem cells
- (2017) Sarah Courtois et al. EUROPEAN JOURNAL OF CANCER
- Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway
- (2017) Chenxiao Yu et al. International Journal of Biological Sciences
- Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway
- (2017) Yi Yang et al. Oncotarget
- Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells
- (2017) Sung-Hee Kim et al. Oncotarget
- Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion
- (2017) Ji-Chang Wang et al. Oncotarget
- MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway
- (2017) Mao Luo et al. Scientific Reports
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
- (2016) Choong-kun Lee et al. ANNALS OF SURGERY
- Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis
- (2016) Danielle K. DePeralta et al. CANCER
- Blocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells
- (2016) Kuo-Chu Lai et al. CANCER LETTERS
- Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
- (2016) Chin-Hsiao Tseng Oncotarget
- Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study
- (2016) Gustav Andersson et al. Biology of Sex Differences
- Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3
- (2015) John D. Hayes et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo
- (2015) SHINTARO FUJIHARA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models
- (2015) KYONG-HWA JUN et al. ONCOLOGY REPORTS
- Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling
- (2015) Xiang-Lin Tan et al. PANCREAS
- Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells
- (2015) Cheng-Chia Tsai WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma
- (2015) Xingming Jiang et al. Oncotarget
- Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
- (2015) Jichang Wang et al. Oncotarget
- Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
- (2015) Xinke Zhou et al. Oncotarget
- Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells
- (2015) Mario Cioce et al. Oncotarget
- AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell
- (2014) Gang Han et al. CANCER BIOLOGY & THERAPY
- Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
- (2014) Zheng Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
- (2014) HISAAKI MIYOSHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer
- (2014) SOICHIRO HONJO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
- (2014) Eveline A. I. F. Queiroz et al. PLoS One
- Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
- (2014) Altaf Mohammed et al. Translational Oncology
- Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
- (2014) Y Feng et al. Cell Death & Disease
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer
- (2013) S. Spillane et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors
- (2013) V. Nair et al. CARCINOGENESIS
- Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway
- (2013) XIAOLEI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- STAT inhibitors for cancer therapy
- (2013) Muhammad Furqan et al. Journal of Hematology & Oncology
- MicroRNA-192 suppresses liver metastasis of colon cancer
- (2013) L Geng et al. ONCOGENE
- Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
- (2013) Heloisa P. Soares et al. PLoS One
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells
- (2012) Weiguang Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer
- (2012) Jin Ha Lee et al. DIGESTIVE AND LIVER DISEASE
- MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells through Targeting BCL-2
- (2012) Shudao Xiong et al. International Journal of Biological Sciences
- Antitumor effect of metformin in esophageal cancer: In vitro study
- (2012) MITSUYOSHI KOBAYASHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells
- (2012) NILUFAR ESFAHANIAN et al. Molecular Medicine Reports
- SCF/ -TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
- (2011) P. Rada et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
- (2011) Luis I. Toledo et al. Molecular Oncology
- Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153
- (2011) N. WU et al. NEOPLASMA
- MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells
- (2011) Shipeng Feng et al. NUCLEIC ACIDS RESEARCH
- Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival
- (2010) Hongxia Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
- (2010) Hyung Gyun Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism
- (2010) R Boidot et al. ONCOGENE
- Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis
- (2009) Cong Tang et al. ANTI-CANCER DRUGS
- Antidiabetic Therapies Affect Risk of Pancreatic Cancer
- (2009) Donghui Li et al. GASTROENTEROLOGY
- DNA Damage Response Pathways in Tumor Suppression and Cancer Treatment
- (2008) Yulong Liang et al. WORLD JOURNAL OF SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started